Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Increased apoptosis induction by 121F mutant p53.

E Saller1, E Tom, M Brunori

  • 1Swiss Institute for Experimental Cancer Research (ISREC), CH-1066 Epalinges, Switzerland.

The EMBO Journal
|August 17, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An enhanced workflow for variant interpretation in UniProtKB/Swiss-Prot improves consistency and reuse in ClinVar.

Database : the journal of biological databases and curation·2019
Same author

Gene Ontology annotations and resources.

Nucleic acids research·2012
Same author

Design considerations for array CGH to oligonucleotide arrays.

Cytometry. Part A : the journal of the International Society for Analytical Cytology·2005
Same author

First measurement of the transverse spin asymmetries of the deuteron in semi-inclusive deep inelastic scattering.

Physical review letters·2005
Same author

Ectopic expression of the beta-cell specific transcription factor Pdx1 inhibits glucagon gene transcription.

Diabetologia·2003
Same author

The transcriptional program following p53 activation.

Cold Spring Harbor symposia on quantitative biology·2003

A novel p53 mutant (121F) shows increased DNA binding and apoptosis induction, potentially expanding p53 gene therapy for tumors. This mutant selectively targets cancer cells by overcoming MDM2 feedback mechanisms.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • Mutations in the p53 tumor suppressor gene are common in cancers, typically leading to reduced DNA binding and apoptosis induction.
  • Understanding p53 mutant phenotypes is crucial for developing targeted cancer therapies.

Purpose of the Study:

  • To characterize a novel p53 mutant (121F) with enhanced apoptosis-inducing capabilities.
  • To investigate the mechanisms underlying the increased apoptotic function and altered sequence specificity of the 121F mutant.
  • To identify new p53 target genes involved in apoptosis.

Main Methods:

  • Characterization of p53 mutant binding affinity and apoptosis induction.
  • Analysis of MDM2 transcription activation and feedback regulation.

Related Experiment Videos

  • DNA chip screening of RNA from cells expressing p53 mutants (121F and 277R).

    • Main Results:

    • The 121F p53 mutant exhibits increased DNA binding affinity and apoptosis induction compared to wild-type p53.
    • 121F selectively fails to activate MDM2 transcription, leading to its overexpression and enhanced apoptotic function.
    • Two novel apoptosis mediators, Rad and PIR121, were identified as being better induced by 121F than wild-type p53.
    • The 121F mutant demonstrates tumor cell killing irrespective of p53 status.

    Conclusions:

    • The 121F p53 mutant's potent apoptosis-inducing phenotype results from decreased MDM2 feedback and enhanced expression of specific target genes.
    • The identification of Rad and PIR121 provides new insights into p53-mediated apoptosis pathways.
    • The 121F mutant holds promise for expanding the scope of p53 gene therapy in various tumor types.